Ansgar Heck

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Reassuring long-term data on efficacy and safety of pegvisomant monotherapy in a large series of patients with acromegaly.

Reassuring long-term data on efficacy and safety of pegvisomant monotherapy in a large series of patients with acromegaly.

Journal: Pituitary

Published: May 29, 2026

Continuous white-light/indocyanine green overlay endoscopy in pituitary adenoma surgery: A prospective feasibility and safety study.

Continuous white-light/indocyanine green overlay endoscopy in pituitary adenoma surgery: A prospective feasibility and safety study.

Journal: Brain & spine

Published: March 14, 2026

Management of acromegaly beyond primary surgery: efficacy and safety of repeat surgery and radiotherapy.

Management of acromegaly beyond primary surgery: efficacy and safety of repeat surgery and radiotherapy.

Journal: Acta neurochirurgica

Published: May 16, 2025

rhPTH(1-84) for hypoparathyroidism: a randomized study of patient-reported outcomes.

rhPTH(1-84) for hypoparathyroidism: a randomized study of patient-reported outcomes.

Journal: European journal of endocrinology

Published: May 12, 2025

X-linked hypophosphataemia.

X-linked hypophosphataemia.

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: March 05, 2025

Pasireotide as first line medical therapy for selected patients with acromegaly.

Pasireotide as first line medical therapy for selected patients with acromegaly.

Journal: Pituitary

Published: March 05, 2025

Correction: X-linked hypophosphataemia

Correction: X-linked hypophosphataemia

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: March 05, 2025

Indocyanine green fluorescence in endoscopic transsphenoidal resection of pituitary neuroendocrine tumors: a systematic review.

Indocyanine green fluorescence in endoscopic transsphenoidal resection of pituitary neuroendocrine tumors: a systematic review.

Journal: Acta neurochirurgica

Published: January 15, 2025

Correction: Genome‑wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors.

Correction: Genome‑wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors.

Journal: Acta neuropathologica

Published: January 03, 2025

Precision Medicine in Acromegaly: The Potential of Multimodal Therapy.

Precision Medicine in Acromegaly: The Potential of Multimodal Therapy.

Journal: The Journal of clinical endocrinology and metabolism

Published: August 14, 2024

Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors.

Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors.

Journal: Acta neuropathologica

Published: July 20, 2024

No effect of surgery on kidney and cardiovascular risk factors in mild primary hyperparathyroidism: secondary analyses from a 10-year randomized controlled trial.

No effect of surgery on kidney and cardiovascular risk factors in mild primary hyperparathyroidism: secondary analyses from a 10-year randomized controlled trial.

Journal: European journal of endocrinology

Published: May 27, 2024

Showing 1-12 of 46

Last Updated: 09/26/2026